| I |
|
IDENFICATION OF THE RECEPTORS IMPLICATED IN THE ENDOCYTOSIS OF FACTOR VIII BY HUMAN DENDRITIC CELLS
|
| Navarrete A.M., Dasgupta S., Delignat S., Yohann R., Wootla B., Bayry J., Kaveri S.V., Lacroix-Desmazes S. |
| |
|
IDENTIFICATION AND EXPRESSION OF R763G MUTATION ABOLISHING THE CLEAVAGE OF VON WILLEBRAND FACTOR PROPEPTIDE, AT THE HETEROZYGOUS AND HOMOZYGOUS STATE
|
| Hilbert L., Nurden P., Guicheteau M., Caron C., Mazurier C. |
| |
|
IDENTIFICATION OF 8 NOVEL MUTATIONS IN THE NON-MUSCLE MYOSIN HEAVY CHAIN 9 (MYH9) GENE IN 11 UNRELATED PATIENTS WITH MACROTHROMBOCYTOPENIA
|
| Saposnik B., Binard S., Elbaz S., Nurden A., Nurden P., Fenneteau O., Hurtaud-Roux M.F., Alessi M.C., Boinot C., Favier R., Bellucci S., Schlegel N., the French Reference Center for Inherited Platelet Disorders |
| |
|
IDENTIFICATION OF A BINDING SITE FOR FACTOR XA ON THE LIGHT CHAIN OF FACTOR VA
|
| Bukys M.A., Orban T., Beck D.O., Smith K.M., Kalafatis M. |
| |
|
IDENTIFICATION OF A CLINICALLY RELEVANT GENE THERAPY STRATEGY TO TREAT HEMOPHILIA A USING A HIGH-EXPRESSION FACTOR VIII VECTOR AND GENETICALLY-MODIFIED HEMATOPOIETIC STEM CELLS
|
| Ide L.M., Gangadharan B., Doering C.B., Spencer H.T. |
| |
|
IDENTIFICATION OF A LOCUS FOR THE QUEBEC PLATELET DISORDER USING GENETIC LINKAGE ANALYSIS
|
| Diamandis M., Paterson A.D., Bulman D.E., Waye J.S., Rommens J.M., Rivard G.E., Hayward C.P.M. |
| |
|
IDENTIFICATION OF A MICROTUBULE ASSOCIATED PROTEIN, BICAUDAL-D1, AS A NOVEL REGULATOR OF PAR1-G PROTEIN SIGNALING
|
| Kuliopulos A., Covic L. |
| |
|
IDENTIFICATION OF A NOVEL ENDOTHELIAL CELL RECEPTOR FOR FIBRIN
|
| Medved L., Yakovlev S., Mikhailenko I., Strickland D.K. |
| |
|
IDENTIFICATION OF A NOVEL MECHANISM PROMOTING STATIONARY ADHESION OF DISCOID PLATELETS SHEAR DEPENDENT CONVERSION OF PLATELET TETHERS TO PSEUDOPODIA
|
| Westein E., Nesbitt W.S., Dopheide S.M., Jackson S.P. |
| |
|
IDENTIFICATION OF AMINO ACID RESIDUES RESPONSIBLE FOR VON WILLEBRAND FACTOR BINDING TO SULFATIDES BY CHARGED TO ALANINE SCANNING MUTAGENESIS
|
| Nakayama T., Matsushita T., Sadler J., Katsumi A., Kojima T., Naoe T., Saito H. |
| |
|
IDENTIFICATION OF ANERGY-RELATED GENES IN IDIOPATHIC THROMBOCYTOPENIC PURPURA USING MICROARRAY ANALYSIS
|
| Zhang X.L., Peng J., Sun J.Z., Hou M. |
| |
|
IDENTIFICATION OF CRITICAL RESIDUES IN A GPVI BINDING PEPTIDE
|
| Jarvis G.E., Raynal N., Bihan D., Farndale R.W. |
| |
|
IDENTIFICATION OF DELETIONS IN WOMEN WITH FAMILY ANTECEDENTS OF SEVERE HAEMOPHILIA B BY MULTIPLE LIGATION PROBE AMPLIFICATION METHOD. COMPARISON WITH QUANTITATIVE REAL-TIME ASSAY
|
| Casaña P., Cabrera N., Oltra J., Cid A., Haya S., Aznar J. |
| |
|
IDENTIFICATION OF ETS1 AS ASE BINDING PROTEIN: UNIQUE ROLE IN AGE-RELATED GENE REGULATION
|
| Kurachi S., Zhang K., Kasama E., Kurachi K. |
| |
|
IDENTIFICATION OF FACTOR VIII GENE MUTATIONS IN 120 HAEMOPHILIA A PATIENTS: DETECTION OF 26 NOVEL MUTATIONS AND CORRELATION WITH FVIII INHIBITOR DEVELOPMENT
|
| Repesse Y., Ferandiz D., Slaoui M., Gautier P., Le Querrec A., Lavergne J., Borel Derlon A. |
| |
|
IDENTIFICATION OF GENETIC SEQUENCES CORRESPONDING TO FACTORS V AND VIII IN A LAMPREY TRACE DATABASE
|
| Doolittle R.F., Jiang Y. |
| |
|
IDENTIFICATION OF MULTIPLE SPLICE VARIANTS OF PHOSPHOLIPID SCRAMBLASE 1
|
| Hayashi A., Matsumoto S., Yoshitome S., Sugimoto I., Hashimoto E., Suzuki K., Takeya H. |
| |
|
IDENTIFICATION OF NOVEL PLATELET MEMBRANE PROTEINS USING MULTI-DIMENSIONAL PROTEIN IDENTIFICATION TECHNOLOGY
|
| Stalker T.J., Yocum A., Wu J., Blair I., Brass L.F. |
| |
|
IDENTIFICATION OF NOVEL TYROSINE PHOSPHORYLATED SIGNALLING PROTEINS FOLLOWING IIb3-MEDIATED PLATELET SPREADING: INVOLVEMENT OF THE IMMUNOGLOBULIN SUPERFAMILY MEMBERS G6B-B AND G6F, AND THE NOVEL PLATELET ADAPTER DOK-3
|
| García A., Senis Y.A., Antrobus R., Hughes C.E., Hughan S.C., Watson S.P., Zitzmann N. |
| |
|
IDENTIFICATION OF PF4 AND BETA-TG BY PROFILING AND LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY OF SUPERNATANT PEPTIDES IN STORED APHERESIS AND BUFFY-COAT PLATELET CONCENTRATES
|
| Wurtz V., Hechler B., Ohlmann P., Isola H., Schaeffer-Reiss C., Cazenave J.P., Van Dorsselear A., Gachet C. |
| |
|
IDENTIFICATION OF POTENT CYCLIC PEPTIDES THAT BIND TO PLATELET GLYCOPROTEIN IB ALPHA AND SELECTIVELY INHIBIT VON WILLEBRAND FACTOR DEPENDENT HIGH-SHEAR PLATELET AGGREGATION
|
| Smith T.M., Benard S., Jacob J., Tsao D., Cunningham K., DeSilva T., Lin L., Carter L., Shaw G., Kriz R., Schaub R., Kelleher K. |
| |
|
IDENTIFICATION OF PROTEOLYTIC CLEAVAGE
|
| Philippou H., Adamson P.J., Grant P.J. |
| |
|
IDENTIFICATION OF TWO DE NOVO ANTITHROMBIN TYPE I MUTATIONS
|
| Orlando C., Jochmans K., Lissens W., Liebaers I., De Waele M. |
| |
|
IDENTIFICATION OF TYPE 2M VON WILLEBRAND DISEASE BY DENSITOMETRIC ANALYSIS OF VON WILLEBRAND FACTOR MULTIMER PATTERNS
|
| Meiring M.S., Kelderman M., Badenhorst P.N. |
| |
|
IDENTIFICATION OF VEGF RECEPTOR-BINDING SITES OF KDR-BINDING PROTEIN
|
| Fujisawa D., Yamazaki Y., Morita T. |
| |
|
IDENTIFICATION OF VON WILLEBRAND DISEASE TYPE 2N BY VWF-FVIII BINDING ACTIVITY ASSAY IN PATIENTS AND HETEROZYGOUS CARRIERS
|
| Sahud M.A., Zhukov O., Popov J., Ramos R., Sferruzza A., Dlott J. |
| |
|
IDIOPATHIC FETAL GROWTH RESTRICTION (FGR) IS ASSOCIATED WITH DECREASED ANTICOAGULANT PROTEOGLYCAN DECORIN EXPRESSION IN HUMAN PLACENTA
|
| Swann B., Murthi P., Said J., Ignjatovic V., Monagle P., Brennecke S. |
| |
|
IDIOPATHIC THROMBOCYTOPENIC PURPURA AND OPPORTUNISTIC INFECTIONS IN CHILDREN
|
| Petrov V.J., Soskov G.I., Ageenkova E.V., Sirotkina N.N. |
| |
|
IGA CLASS OF AUTOANTIBODIES AGAINST ADAMTS13 IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA
|
| Ferrari S.E., Rieger M., Mudde G.C., Veyradier A., Plaimauer B., Scheiflinger F. |
| |
|
IGE SPECIFIC FOR HUMAN FVIII FROM A PATIENT WITH HEMOPHILIA A BINDS TO THE C2 DOMAIN AND INHIBITS FVIII FUNCTION
|
| Königs C., Klich K., Kessel C., Heller C., Aygören-Pürsün E., Stoll H., Kadar J.G., Kreuz W. |
| |
|
IGG ANTIBODIES WITH HYDROLYTIC ACTIVITY TOWARDS ENDOGENOUS FVIII IN A FRENCH COHORT OF PATIENTS WITH ACQUIRED HEMOPHILIA
|
| Wootla B., Friboulet A., Christophe O., Levesque H., Borg J., Kaveri S.V., Lacroix-Desmazes S. |
| |
|
IGG SUBCLASS DISTRIBUTION OF ANTIBODIES AGAINST ADAMTS13 IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA
|
| Ferrari S.E., Rieger M., Mudde G.C., Kremer Hovinga J., Veyradier A., Plaimauer B., Lämmle B., Scheiflinger F. |
| |
|
IGM ANTI PROTEIN S ANTIBODIES AS A RISK FACTOR OF VENOUS THROMBOSIS
|
| Borrell M., Tirado I., Ortin R., Mateo J., Felices R., Santamaria A., Montserrat I., Fontcuberta J. |
| |
|
IL 1A 899C/T AND IL4 589C/T ARE ASSOCIATED WITH VENOUS THROMBOEMBOLISM
|
| Beckers M., Ruven H., Prins M., Biesma D. |
| |
|
IL-1BETA-INDUCED TISSUE-TYPE PLASMINOGEN ACTIVATOR SUPPRESSION IN VASCULAR ENDOTHELIAL CELLS IS MEDIATED BY NF-KAPPAB SIGNALING
|
| Larsson P.M., Ulfhammer E., Karlsson L., Bokarewa M., Wåhlander K., Jern S. |
| |
|
ILIOPSOAS ABSCESS IN A 4-YEAR-OLD BOY WITH SEVERE HAEMOPHILIA
|
| Mortazavi S.J. |
| |
|
ILPCA, A RECOMBINANT PC ACTIVATOR SUCCESSFULLY USED TO FORMULATE AN AUTOMATED PC CHROMOGENIC ASSAY IN LIQUID FORMAT
|
| Sanchez-Martinez D., Diaz D., Smirnov M., Triscott M. |
| |
|
IMAGE ANALYSIS OF LYMPHOCYTES CHROMATIN AT THE APOPTOSIS
|
| Akulich N.V., Osipenko A.N., Vishnevskaya S.M., Kruchinsky N.G. |
| |
|
IMAGING OF BLOOD PLASMA COAGULATION AND ITS PROPAGATION AT SURFACES
|
| Faxälv L., Lindahl T.L., Tengvall P. |
| |
|
IMMUNE RESPONSE AFTER FIRST AND SECOND IV INJECTION OF AVIDIN USED AS THE NEUTRALIZING AGENT FOR BIOTINYLATED IDRAPARINUX
|
| Paty I., Paquet N., Sibille M., Cortez P., Berard F., Nicolas J.F. |
| |
|
IMMUNE RESPONSE TO ADMINISTRATION OF PLASMA-DERIVED COAGULATION FACTOR VIII IN FACTOR VIII-DEFICIENT MICE
|
| Kallas A., Kuuse S., Maimets T., Pooga M. |
| |
|
IMMUNE TOLERANCE IN AN ADULT AFTER A LONG TERM HISTORY OF I,HIBITOR
|
| de Raucourt E., Matingou M., Pertuiset N., Rothschild C., Torchet M. |
| |
|
IMMUNE TOLERANCE INDUCTION (ITI) IN PATIENTS WITH HEMOPHILIA A AND INHIBITORS: THE ITALIAN RETROSPECTIVE-PROSPECTIVE REGISTRY - THE PROFIT STUDY
|
| Santagostino E., Coppola A., Tagliaferri A., Mancuso M.E., Scaraggi F.A., Biasoli C., Schinco P.C., Iorio A., Latella C., Di Minno G. |
| |
|
IMMUNE TOLERANCE INDUCTION FOR KOREAN HEMOPHILIACS WITH INHIBITORS
|
| k. Yoo S., Baik H.J., Kang S.Y., Choi E.J., Yoon H.J. |
| |
|
IMMUNE TOLERANCE INDUCTION TO FVIII IN HEMOPHILIA A MICE USING SUBCUTANEOUSLY IMPLANTED FVIII GENE-MODIFIED ENDOTHELIAL PROGENITOR CELLS
|
| Matsui H., Labelle A., Hegadorn C., Thompson P., Burnett E., Hough C., Lillicrap D. |
| |
|
IMMUNE TOLERANCE INDUCTION WITH VIII-CONTAINING FACTOR VWF
|
| Fernandez-Morata R., Quintana M., Alvarez M., Martin M., Jimenez Yuste V., Hernandez Navarro F. |
| |
|
IMMUNE TOLERANCE THERAPY FOR FACTOR VIII INHIBITORS: MOVING FROM EMPIRICISM TO AN EVIDENCE - BASED APPROACH
|
| DiMichele D. |
| |
|
IMMUNE-TOLERANCE IN HAEMOPHILIA A USING PLASMA-DERIVED FACTOR VIII CONCENTRATE FANHDI
|
| Needham J., Roy A., Stebbings Y., Lewis H., Mathias G. |
| |
|
IMMUNOGLOBULIN ISOTYPES AND FUNCTIONAL ANTI-FVIII ANTIBODIES IN RESPONSE TO FVIII TREATMENT IN TWO STRAINS OF HEMOPHILIA A MICE
|
| Qadura M., Othman M., Labelle A., Burnett E., Thompson P., Hough C., Lillicrap D. |
| |
|
IMMUNOGLOBULINE ANTI-D (WINRHO) IN CRHONIC CHILDOOD IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP), ANALYSIS OF "IMMATURE PLATELET FRACTION (I.P.F.)" AND ASYMPTOMATIC THROMBOCYTOPENIA
|
| Mancuso G., Gagliano F., Licastro G., Calabrò M., Diquattro M. |
| |
|
IMMUNO-MAGNETIC ENRICHMENT FOLLOWED BY MULTI-PARAMETER FLOW CYTOMETRY: A NEW APPROACH TO COUNT CIRCULATING ENDOTHELIAL CELLS
|
| Widemann A., Arnaud L., Sabatier F., Bonello L., Massarani G., Dignat-George F. |
| |
|
IMMUNO-PURIFICATION OF PLASMA ADAMTS13 AND ITS PHYSICO-CHEMICAL CHARACTERIZATION
|
| Hiura H., Isonishi A., Kato S., Matsumoto M., Matsui T., Fujimura Y. |
| |
|
IMPACT OF CENTRIFUGATION CONDITIONS ON PLATELETS AND COAGULATION TESTING
|
| von Pape K.W., Weisser H. |
| |
|
IMPACT OF FVIII PRODUCT CHANGE IN SEVERE HAEMOPHILIA A PATIENTS PREVIOUSLY TREATED WITH PLASMA-DERIVED FVIII
|
| Mingot M.E., Bardan D., Martín A., Heiniger A. |
| |
|
IMPACT OF PROPHYLACTIC ADMINISTRATION OF FFP ON HYPOFIBRINOGENEMIA IN PAEDIATRIC PATIENTS TREATED WITH L-ASPARAGINASE FOR ACUTE LYMPHOBLASTIC LEUKAEMIA
|
| Brasseur B., Vermylen C., Hermans C. |
| |
|
IMPACT OF RENAL FUNCTION ON THE BENEFIT-RISK RATIO OF FONDAPARINUX IN PATIENTS WITH NON-ST ELEVATION ACUTE CORONARY SYNDROMES IN THE OASIS-5 TRIAL
|
| Fox K.A., Mehta S.R. |
| |
|
IMPACT OF RISK FACTORS ASSOCIATED WITH VENOUS THROMBOSIS IN CYPROTERONE ACETATE AND ETHYNIL-ESTRADIOL USERS OR OTHER ORAL CONTRACEPTIVES USERS AND POSSIBLY PREVENTABLE CASES
|
| Conard J., Plu-Bureau G., Adida K., Horellou M. |
| |
|
IMPACT OF THE VITAMIN K EPOXIDE REDUCTASE COMPLEX SUBUNIT 1 (VKORC1) POLYMORPHISM C.-1639GA UPON PHENPROCOUMON THERAPY
|
| Schneider K., Luxembourg B., Geisen C., Sittinger K., Seifried E., Lindhoff-Last E. |
| |
|
IMPACT OF TISSUE FACTOR-BEARING MICROPARTICLES DERIVED FROM TUMOR CELLS ON COAGULATION ACTIVATION
|
| Davila M., Amirkhosravi A., Coll E., Robles L., Baker C.H., Abdelrahim M., Colon J., Francis J. |
| |
|
IMPACT OF VENOUS THROMBOEMBOLISM, VENOUS STASIS SYNDROME, VENOUS OUTFLOW OBSTRUCTION AND VENOUS VALVULAR INCOMPETENCE ON QUALITY OF LIFE AND ACTIVITIES OF DAILY LIVING: A POPULATION-BASED CASE-CONTROL STUDY
|
| Ashrani A.A., Heit J.A., Rooke T.W., Lahr B.D., Petterson T.M., Bailey K.R., Melton III L.J. |
| |
|
IMPACTS OF GENETIC TESTING FOR THROMBOPHILIA ON FIRST DEGREE RELATIVES OF PATIENTS WITH VENOUS THROMBOEMBOLISM AND A THROMBOPHILIA - A CROSS-SECTIONAL SURVEY
|
| Louzada M.L., Wells P.S., Rodger M.A., Dunn C.R., Wilson B. |
| |
|
IMPAIRED ANGIOGENESIS AND ENHANCED INTRACRANIAL VASCULAR APOPTOSIS IN A MURINE MODEL OF FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA (FNAITP)
|
| Yang H., Chen P., Boyd S.R., Piran S., Hynes R.O., Freedman J., Ni H. |
| |
|
IMPAIRED BINDING OF THROMBIN TO THROMBOMODULIN IS ASSOCIATED WITH RISK OF DEEP VEIN THROMBOSIS
|
| Suehisa E., Kawasaki T., Toku M., Hidaka Y. |
| |
|
IMPAIRED BINDING OF THROMBIN TO THROMBOMODULIN IS ASSOCIATED WITH RISK OF DEEP VEIN THROMBOSIS
|
| Suehisa E., Kawasaki T., Toku M., Hidaka Y. |
| |
|
IMPAIRED EFFICACY OF CLOPIDOGREL IN PATIENTS WITH A ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
|
| van Werkum J.W., Heestermans A.A.C.M., Taubert D., von Beckerath N., Seesing T.H., Schömig E., Hackeng C.M., ten Berg J.M. |
| |
|
IMPAIRED 'OUTSIDE-IN' INTEGRIN ALPHAIIBBETA3 SIGNALING AND THROMBUS STABILITY IN CD151 AND TSSC6-DEFICIENT MICE
|
| Jackson D.E., Lau L.M., Goschnick M.W., Wee J.L., Liu Y.S., Hogarth M.P., Robb L.M., Hickey M.J., Wright M.D., Ashman L.K. |
| |
|
IMPAIRED REGULATION OF PLATELET 12-LIPOXYGENASE (ALOX12) WITH CBFA2/RUNX1 HAPLODEFICIENCY
|
| Kaur G., Jalagadugula G.S., Rao A.K. |
| |
|
IMPAIRED RESPONSIVENESS OF PLATELETS TO EPINEPHRINE IN CHINESE RELATED TO A2A ADRENOCEPTOR POLYMORPHISMS
|
| Lin T., Lin J., Chen T., Wang Y., Yang Y. |
| |
|
IMPAIRED THROMBOPOIESIS AFTER STEM CELL INFECTION WITH JUNIN VIRUS
|
| Pozner R.G., Pacienza N., Negrotto S., D'Atri L.P., Ure A., Torres O., Romanowski V., Schattner M., Gomez R.M. |
| |
|
IMPLEMENTATION OF A TREATMENT PROTOCOL FOR PEDIATRIC ITP IN A LARGE CHILDREN'S HOSPITAL
|
| Lomax C. |
| |
|
IMPLEMENTATION OF SYSTEM CHANGE IMPROVES VENOUS THROMBOEMBOLISM PROPHYLAXIS
|
| Collins R.D., Gibbs H., Gibbs J. |
| |
|
IMPLEMENTING AN EXTERNAL QUALITY ASSESSMENT PROGRAMME FOR USERS OF COAGUCHEK XS AND COAGUCHEK XS PLUS FOR MONITORING INRS
|
| Kitchen D.P., Kitchen S., Jennings I., Woods T.A.L., Walker I.D. |
| |
|
IMPORTANCE OF FIBRIN BINDING FOR THERAPEUTIC EFFICACY OF DIRECT THROMBOLYTICS
|
| Novokhatny V., Bromirski J., Hunt J., Scuderi P., Petteway S. |
| |
|
IMPROVED PROCOAGULANT AND PHARMACOKINETIC PROPERTIES OF TWO NOVEL RECOMBINANT HUMAN FACTOR VIIA VARIANTS PREPARED BY DIRECTED MOLECULAR EVOLUTION AND RATIONAL DESIGN
|
| Bornaes C., Jensen R.B., Röpke M., Breinholt V.M., Nygaard F.B., Halkier T., Andersen K.V., Kisiel W., Haaning J. |
| |
|
IMPROVED THERAPEUTIC AGENTS FOR HEMOPHILIA
|
| Lollar P. |
| |
|
IMPROVEMENT OF THIOLACTONASE ACTIVITY OF PARAOXONASE 1 BY SIMVASTATIN IN PATIENTS WITH CORONARY ARTERY DISEASE
|
| Domagala T.B., Grzanka P., Kotula-Horowitz K., Szczeklik A. |
| |
|
IMPROVING COMMUNICATION AND SUPPORTING EFFICIENT PRODUCT USE WITH ELECTRONIC RECORDING
|
| Schwetz N., Jacobson R., Israels S.J. |
| |
|
IMPROVING PATIENT SAFETY WHEN STARTING WARFARIN IN THE HOSPITAL: THE WARFDOCS STUDY
|
| White R.H., Harvey D.J., Neufeld J., Hogarth M., Lin T., Dager W., King J., Kravitz R.L. |
| |
|
IMPROVING RECOMBINANT FACTOR VIII (RFVIII) DOSING PRECISION IN THE TREATMENT OF HEMOPHILIA A RESULTS IN POTENTIAL COST SAVINGS
|
| Epstein J., Kwon J., Bonnet P. |
| |
|
IMPROVING THE PHARMACOKINETICS OF RECOMBINANT FACTOR VIIA CYS407 BY CYSTEINE-DIRECTED PEGYLATION
|
| Ostergaard H., Groth A.V., Krogh T.N., Petersen J.M., Krarup J., Sørensen B.B., Stennicke H.R. |
| |
|
IN HUMAN MACROPHAGES THE COMPLEMENT COMPONENT C5A INDUCES THE EXPRESSION OF ONCOSTATIN M VIA AP-1 ACTIVATION
|
| Kastl S.P., Speidl W.S., Katsaros K.M., Kaun C., Huber K., Wojta J. |
| |
|
IN PERIODONTAL DISEASE THE INFLAMMATORY STATE IS ASSOCIATED WITH SUB-CLINICAL ATHEROSCLEROSIS
|
| Gori A.M., Cairo F., Cesari F., Bacci M., Falciani M., Pucci N., Castellani S., Pini Prato G.P., Gensini G.F., Abbate R. |
| |
|
IN VITRO AND EX VIVO PROPERTIES OF LONG-ACTING REVERSIBLE OLIGOSACCHARIDES
|
| Herault J., Millet L., Savi P., Duchaussoy P., Petitou M., Schaeffer P., Bono F., Herbert J. |
| |
|
IN VITRO ASSESSMENT OF ANTICOAGULATION REVERSAL WITH ROTEM THROMBOELASTOMETRY
|
| Gatt A., van Veen J.J., Woolley A., Cooper P.C., Kitchen S., Makris M. |
| |
|
IN VITRO EFFECTS OF LEPIRUDINE, DANAPAROID AND FONDAPARINUX ON THROMBIN GENERATION IN HIT PLASMAS
|
| Tardy-Poncet B., Piot M., Tardy B., Mismetti P. |
| |
|
IN VITRO INHIBITION OF MONOCYTE TISSUE FACTOR AND PAI-2 PRODUCTION BY OCHRATOXIN A
|
| Rossiello M.R., Rotunno C., Carratù M.R., Semeraro N., Colucci M. |
| |
|
IN VITRO PLATELET AGGREGATION OF PAPUAN SNAKE VENOMS
|
| Summerhayes R., Ignjatovic V., Williams D., Winkel K., Monagle P.T. |
| |
|
IN VITRO SIMULATION OF BRIDGING THERAPY WITH LMWH AND VITAMIN K ANTAGONISTS. EFFECT ON THROMBIN GENERATION
|
| Gerotziafas G.T., Dupont C., Elalamy I., Samama M.M., Verdy E. |
| |
|
IN VITRO STUDY OF THE EFFECT OF EXPOSURE OF HUMAN BLOOD TO ADDED INSULIN AND GLUCOSE OVER 24 HOURS AT 20 DEGREES C AND ITS MODULATION BY WORTMANNIN (W)
|
| Murer E.H., London F. |
| |
|
IN VIVO AND IN VITRO EFFECTS OF RECOMBINANT ACTIVATED FACTOR VII ON THE PLATELET PROTEOME
|
| Mathijssen N.C.J., Loof A.H., Van Kraaij M.G.J., Nováková I.R.O., Van Heerde W.L. |
| |
|
IN VIVO ANTITHROMBOTIC ACTIVITY OF PROTEIN S (PS) THAT IS INDEPENDENT OF APC
|
| Heeb M.J., Marzec U., Gruber A., Hanson S.R. |
| |
|
IN VIVO ASSESSMENT OF EXPERIMENTAL MELANOMA METASTASIS BY INTRAVITAL MICROSCOPY REVEALS A CRITICAL ROLE OF PLATELETS AND GLYCOPROTEIN IIB
|
| Schulz C., Schürzinger K., Hofmaier S., Enders G., Frampton J., Massberg S. |
| |
|
IN VIVO AVAILABILITY OF TWO RECOMBINANT FACTOR VIII PRODUCTS
|
| Balliel W.M.R., Dielis A.W.J.H., van Oerle R., Hermens W.T., ten Cate H., Hamulyák K. |
| |
|
IN VIVO EFFECTS OF HYPERTHERMIA ON THE FUNCTIONAL AND CONFORMATIONAL CHARACTERISTICS OF ANTITHROMBIN
|
| Hernandez-Espinosa D., Mota R., Miñano A., Ordoñez A., Yelamos J., Vicente V., Corral J. |
| |
|
IN VIVO EFFECTS OF MURINE AND HUMAN APC
|
| Furlan Freguia C., Schuettrumpf J., Zou J., Schlachterman A., Downey H.D., Baila S., Zhou S., Arruda V.R. |
| |
|
IN VIVO MONITORING OF THROMBUS FORMATION
|
| Furie B.C., Furie B. |
| |
|
IN VIVO PHARMACOLOGICAL STUDIES OF AN ANTI-GPVI ANTIBODY THAT IMMUNODEPLETES GPVI WITHOUT PLATELET ACTIVATION
|
| Shinozaki M., Takahashi H., Honda M., Yatagai Y., Kawahara T., Naitoh K., Hirose J., Nakayama K., Hosaka Y., Furusako S., Takayama H. |
| |
|
IN VIVO RECOVERY OF RISTOCETIN CO-FACTOR IN PATIENTS WITH VON WILLEBRAND DISEASE UNDERGOING PROCEDURES REQUIRING TREATMENT WITH HAEMATE P
|
| Watt S.G., Nash M., Walsh M.L., Birtwistle L., Bolton-Maggs P., Hay C.R.M. |
| |
|
IN VIVO STUDIES OF NEWLY IDENTIFIED PLATELET-SPECIFIC GENES BY HUMAN PLATELET FORMATION IN NOD/SCID MICE AFTER TRANSPLANTATION OF CD34-POSITIVE CELLS
|
| Tijssen M.R., Thijssen-Timmer D.C., van der Schoot E.C., Zwaginga J.J., Voermans C. |
| |
|
IN VIVO THROMBUS FORMATION
|
| Furie B.C., Furie B. |
| |
|
IN VIVO-ASSAY FOR WARFARIN-RESISTANCE BY COEXPRESSION OF VKORC1 AND VITAMIN K-DEPENDENT COAGULATION FACTORS
|
| Fregin A., Taverna M., Rost S., Mueller-Reible C.R., Oldenburg J. |
| |
|
INACCURACY OF POINT-OF-CARE (POC) WHOLE BLOOD INR AT INR VALUES GREATER THAN 4
|
| Chodirker L., Selby R., Rozmanc M., Bartle W., Huth B., Geerts W., Jay R. |
| |
|
INACTIVATION OF ALPHA-1-PROTEASE INHIBITOR DURING CLINICAL SEPSIS-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION IS NOT CONSISTENT WITH INHIBITOR POLYMERIZATION
|
| Samis J.A., Toh C., Downey C., Fournier D.J., Nesheim M.E. |
| |
|
INACTIVE TISSUE FACTOR CONTAINING EXPOSED THIOLS RESIDES ON THE SURFACE OF UNSTIMULATED ENDOTHELIAL CELLS
|
| Atkinson B.T., Kos C., Furie B.C., Furie B. |
| |
|
INADEQUATE CARDIOVASCULAR PREVENTION AND DIAGNOSTIC VASCULAR GUIDELINES ADHERENCE IN OUTPATIENTS: AN OBSERVATIONAL STUDY IN A COHORT OF NORTHERN ITALY
|
| Marzolo M., Verlato F., Zotta L., Guadagnin M.L., Borgese L., Cravatari M., Nardi M.T., Camporese G., Andreozzi G.M. |
| |
|
INCIDENCE AND DISEASE PATTERN OF VENOUS THROMBEMBOLISM AFTER RADICAL PROSTATECTOMY
|
| Beyer J., Wessela S., Halbritter K., Hakenberg O., Wirth M., Schellong S. |
| |
|
INCIDENCE OF ANTI-HEPARIN/PLATELET FACTOR 4 (AHPF4) ANTIBODIES AND HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) IN MEDICAL PATIENTS
|
| Demir M., Duran E., Yigitbasi O., Vural O., Kurum T., Yuksel M., Turgut B., Tekgunduz E., Walenga J.M., Fareed J. |
| |
|
INCIDENCE OF ANTITHROMBIN LEVEL ON "HEMOFILTER CIRCUIT" THROMBOSIS DURING EARLY CONTINUOUS VENOVENOUS HEMOFILTRATION IN POST CARDIOPULMONARY BYPASS PATIENTS
|
| Lanquetot H., Leprince T., Boinot C., Ragot S., Jayle C., Macchi L. |
| |
|
INCIDENCE OF DEEP VEIN THROMBOSIS (DVT) IN NON-SURGICAL PATIENTS AT HOSPITAL ADMISSION
|
| Hoffmanns P., Lawall H., Hoffmanns W., Pira A., Rapp U., Diehm C. |
| |
|
INCIDENCE OF LEUKEMIA IN PATIENTS WITH HEMOPHILIA
|
| Dunn A.L., J.M. Soucie . |
| |
|
INCIDENCE OF PULMONARY THROMBOEMBOLISM IN AUTOPSY CASES IN A JAPANESE GENERAL HOSPITAL
|
| Sakon M., Yamashita S., Nakagawa S., Hayashida H., Higaki N., Niinobu T., Ichihara T., Ayata M. |
| |
|
INCIDENCE OF THE VARIOUS HEPARIN DEPENDENT ANTIBODY ISOTYPES IN A GROUP OF PATIENTS WITH HEPARIN INDUCED THROMBOCYTOPENIA
|
| Vissac A.M., Catala M., Amiral J.J. |
| |
|
INCREASE IN NATTOKINASE ACTIVITY AND VITAMIN K2 CONTENT CAUSED BY DIPICOLINIC ACID
|
| Sumi H., Ikeda S., Yatagai C., Naito S., Saito J. |
| |
|
INCREASED ADHESION TO ENDOTHELIAL CELLS OF ERYTHROCYTES FROM PATIENTS WITH POLYCYTHEMIA VERA IS MEDIATED BY LAMININ ALPHA5 CHAIN AND LU/BCAM
|
| Wautier M., El Nemer W., Gane P., Rain J., Le Vankim C., Wautier J. |
| |
|
INCREASED AGE RELATED EXPRESSION OF FVIII IN TWO UNRELATED FEMALES WITH SEVERE HEMOPHILIA A AND NONRANDOM X-INACTIVATION
|
| Gruppo R.A., Davies S., Balasa V.V. |
| |
|
INCREASED ARACHIDONIC/LINOLEIC RATIO AND A POLYGENIC MODEL OF DESATURASE POLYMORPHIMS ARE ASSOCIATED WITH INCREASED RISK OF CORONARY ARTERY DISEASE
|
| Martinelli N., Girelli D., Guarini P., Malerba G., Illig T., Trabetti E., Friso S., Pizzolo F., Bozzini C., Schaeffer L., Heinrich J., Pignatti P.F., Corrocher R., Olivieri O. |
| |
|
INCREASED CD39 EXPRESSION PROTECTS KIDNEYS FROM ISCHEMIA REPERFUSION INJURY VIA A REDUCTION IN INFILTRATING CD4+T CELLS: PROTECTION IS AFFORDED BY BOTH EXPRESSIONS ON EITHER TISSUE OR ON CELLULAR BLOOD
|
| Nandurkar H., Crikis S., Dwyer K., Robson S., Murray-Segal L., Cowan P., d'Apice A. |
| |
|
INCREASED CELL ASSOCIATED TISSUE FACTOR ACTIVITY FOLLOWING TOTAL KNEE ARTHROPLASTY
|
| Johnson G.J., Leis L.A., Bach R.R. |
| |
|
INCREASED ENDOGENOUS THROMBIN POTENTIAL (ETP) IN PATIENTS OF FAMILIES WITH INHERITED AT DEFECTS
|
| Rossetto V., Spiezia L., Chiriu A., Gavasso S., Tormene D., Simioni P. |
| |
|
INCREASED EXPRESSION OF AND ENHANCED PLATELET REACTIVITY TO FRACTALKINE IN TYPE-II DIABETIC ZDF-RATS
|
| Schäfer A., Schöpp C., Schulz C., Flierl U., Pfrang J., Massberg S., Bauersachs J. |
| |
|
INCREASED FIBRINOLYISIS ASSOCIATED WITH DEFECTIVE COAGULATION CONTRIBUTES TO IMPAIRMENT OF HEMOSTASIS IN HEMOPHILIA
|
| He S., Eelde A., Blomback M. |
| |
|
INCREASED GENERATION OF ACTIVATED PROTEIN C ASSOCIATED WITH OBESITY. WEIGHT LOSS INFLUENCE
|
| Navarro S., Solá E., Medina P., Vayá A., Hernández A., Estellés A., España F. |
| |
|
INCREASED LEVELS OF D-DIMER IN PATIENTS WITH MYOCARDIAL INFARCTION
|
| Kawasugi K., Simazu C., Noguchi M., Tashiro H., Gotoh M., Shirafuji N., Matsuda J., Miyazawa Y. |
| |
|
INCREASED PLASMA MARKERS OF PLATELET AND PROTHROMBIN ACTIVATION IN PATIENTS WITH THORACIC ASCENDING AORTIC ANEURYSM
|
| Touat Z., Lepage L., Ollivier V., Nataf P., Jandrot-Perrus M., Michel J., Jondeau G. |
| |
|
INCREASED PLASMINOGEN ACTIVITY IS AN INDEPENDENT PREDICTOR OF BLEEDING IN HEMOPHILIACS
|
| Gerhardt A., Pesch M., Scharf R.E., Zotz R.B. |
| |
|
INCREASED PLATELET AGGREGATION AFTER DDAVP ADMINISTRATION MAY BE EXPLAINED BY DECREASED EXPRESSION OF THE TETRASPANIN CD9
|
| Vrelust I., Vangenechten I., Vertessen F., Van der Planken M., Gadisseur A.P. |
| |
|
INCREASED PLATELET PROCOAGULANT ACTIVITY IN TYPE 2 DIABETIC PATIENTS: INHIBITION BY GPIIB/IIIA BLOCKADE
|
| Razmara M., Hjemdahl P., Östenson C., Johansson M., Daleskog M., Li N. |
| |
|
INCREASED TAFI LEVELS AND THE RISK OF THROMBOEMBOLISM
|
| Folkeringa N., Brouwer J.P., Veeger N.J.G.M., van der Meer J. |
| |
|
INCREASED THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI) LEVELS IN EXPERIMENTAL HUMAN ENDOTOXEMIA IS CAUSED BY BOTH INFLAMMATORY RESPONSE AND THROMBIN GENERATION
|
| Antovic J.P., Skeppholm M., Soop A., Albert J., Sollevi A., Mobarrez F., Wallen H.N. |
| |
|
INCREASED THROMBIN GENERATION CAPACITY IN SEPTIC PATIENTS WITH DIC
|
| Kawasugi K., Simazu C., Noguchi M., Tashiro H., Gotoh M., Shirafuji N., Matsuda J., Miyazawa Y. |
| |
|
INCREASING RATE OF VENOUS THROMBOEMBOLISM AMONG HOSPITALIZED CANCER PATIENTS
|
| Khorana A.A., Francis C.W., Culakova E., Kuderer N.M., Lyman G.H. |
| |
|
INDETERMINATE RESULTS ARE COMMON IN LUPUS ANTICOAGULANT TESTING
|
| Kottke-Marchant K., Jang S. |
| |
|
INDIVIDUAL AND CLINICAL PREDICTORS OF THE TIMING OF DIAGNOSIS OF VENOUS THROMBOEMBOLISM: RESULTS FROM THE MASTER REGISTRY
|
| Ageno W., Agnelli G., Imberti D., Moia M., Palareti G., Pistelli R., Rossi R., Verso M. |
| |
|
INDIVIDUAL AND COMBINED EFFECTS OF ASPIRIN AND THIENOPYRIDINES IN ATTENUATION OF PLATELET AGGREGATION INDUCED BY COLLAGEN AND OTHER AGONISTS
|
| Jakubowski J.A., Payne C.D., Li Y.G., Brandt J.T., Naganuma H., Winters K.J. |
| |
|
INDUCTION OF ENDOTHELIAL CELL HYPERPERMEABILITY BY EXTRACELLULAR RNA
|
| Fischer S., Gerriets T., Walberer M., Stolz E., Zheleva K., Wessels C., Kostin S., Preissner K.T. |
| |
|
INDUCTION OF FACTOR VIII SPECIFIC UNRESPONSIVENESS BY INTRATHYMIC FACTOR VIII INJECTION IN MURINE HEMOPHILIA A
|
| Madoiwa S., Yamauchi T., Kobayashi E., Hakamata Y., Ohmori T., Mimuro J., Sakata Y. |
| |
|
INDUCTION OF FIX TOLERANCE BY DIRECT INTRAMUSCULAR INJECTION OF AAV IS AAV-DOSE/FIX-LEVEL DEPENDENT
|
| Cohn E.F., Kelly M.E., Zhuo J., Chao H. |
| |
|
INDUCTION OF PLATELET AGGREGATION BY SAS CANCER CELLS A MECHANISM FOR HEMATOGENOUS METASTASIS OF TONGUE CANCER
|
| Jeng J.H., Chang M.C. |
| |
|
INDUCTION OF TISSUE FACTOR ACTIVITY IN STIMULATED PLATELETS
|
| Panes O., Matus V., Sáez C.G., Pereira J., Mezzano D. |
| |
|
INFERIOR VENA CAVA FILTERS IN PEDIATRIC PATIENTS
|
| Raffini L.J., Cahill A., Hellinger J., Manno C. |
| |
|
INFLAMMATION, ENDOTHELIAL DYSFUNCTION AND ANGIOGENIC ACTIVITY IN STABLE HEART FAILURE PATIENTS
|
| Reganon E., Vila V., Martínez Sales V., Almenar L., Sánchez Lázaro I., Villa P. |
| |
|
INFLUENCE OF A GT REPEAT ELEMENT ON SHEAR STRESS-RESPONSIVENESS OF THE VWF GENE PROMOTER
|
| Hough C.A., Cameron C.L., Notley C.R.P., Brown C., O'Brien L., Keightley A.M., Berber E., Lillicrap D. |
| |
|
INFLUENCE OF ADDING 4% BSA IN THE BETHESDA ASSAY FOR FACTOR VIII INHIBITOR QUANTIFICATION
|
| Moret A., Cortina V., Haya S., Perales M.A., Cid A.R., Aznar J.A. |
| |
|
INFLUENCE OF AGE ON THE COST EFFECTIVENESS OF DIAGNOSTIC STRATEGIES FOR SUSPECTED PULMONARY EMBOLISM
|
| Righini M., Nendaz M., Le Gal G., Bounameaux H., Perrier A. |
| |
|
INFLUENCE OF ANTIEPILEPTIC DRUGS ON THE COAGULATION
|
| Krause M., Pudens C., Kirchmaier C., Großmann R., Gerlach R. |
| |
|
INFLUENCE OF BUYANG HUANWU DECOCTION COMBINED UNSATURAT FATTY ACID IN RATS WITH HYPERLIPIDEMIAED
|
| He X., Wen Z., Wang H., Zhang H., Sun Y., Hu J., He S. |
| |
|
INFLUENCE OF COVALENT ANTITHROMBIN-HEPARIN COMPLEX ON FIBROBLAST GROWTH FACTOR EXPRESSION AND LUNG ANGIOGENESIS
|
| Parmar N., Berry L.R., Chan A.K.C. |
| |
|
INFLUENCE OF CYP2C19 AND CYP3A4 GENE POLYMORPHISMS ON CLOPIDOGREL RESPONSIVENESS IN HEALTHY SUBJECTS
|
| Fontana P., Hulot J., de Moerloose P., Gaussem P. |
| |
|
INFLUENCE OF CYP2C9 GENETIC POLYMORPHISMS ON METABOLIC CLEARANCE, WARFARIN MAINTENANCE DOSE AND BLEEDING COMPLICATIONS IN RUSSIAN PATIENTS
|
| Mikheeva J.A., Kropacheva E., Ignatev I., Bylitova J., Rameskaya G., Sychev D., Dobrovolsky A., Panchenko E. |
| |
|
INFLUENCE OF DESMOPRESSIN ON HEMOSTASIS IN CHILDREN WITH BLEEDING DISORDERS
|
| Hanebutt F.L., Rolf N., Loesel A., Siegert G., Knoefler R. |
| |
|
INFLUENCE OF FACTOR VII 323 DEL/INS POLYMORPHISM IN THE PROTHROMBOTIC STATE AND ISCHAEMIC STROKE RISK IN ATRIAL FIBRILLATION
|
| Roldan V., Marin F., Gonzalez-Conejero R., Corral J., Garcia-Honrubia A., Lip G., Vicente V. |
| |
|
INFLUENCE OF FV LEIDEN ON THE KINETICS OF THROMBIN FORMATION AS DETERMINED BY THE THROMBIN DYNAMICS TEST (TDT)
|
| Calatzis A., Spannagl M., Schramm W. |
| |
|
INFLUENCE OF GENDER AND AGE ON RISK OF RECURRENT VENOUSTHROMBOEMBOLISM (VTE) IN PATIENTS WITH IDIOPATHIC VTE TREATED 5-7 MONTHS OF ORAL ANTICOAGULANT (OAC) THERAPY
|
| Rodger M.A., Kovacs M.J. |
| |
|
INFLUENCE OF HAEMATOCRIT ON ROTEM PARAMETERS
|
| Spiezia L., Marchioro P., Radu C., Chiriu A., Tognin G., Rossetto V., Pagnan A., Simioni P. |
| |
|
INFLUENCE OF HERITABILITY AND HOUSEHOLD COMPONENTS ON LIPID CONCENTRATIONS AND CLOTTING FACTOR LEVELS IN 282 PEDIATRIC STROKE FAMILIES
|
| Nowak-Gottl U., Langer C., Bergs S., Thedieck S., Strater R.D., Stoll M. |
| |
|
INFLUENCE OF HYPERHOMOCYSTEINEMIA ON FIBRINOLYTIC AND ANTICOAGULANT SYSTEMS IN PATIENTS WITH ACUTE CORONARY SYNDROME
|
| Smirnova O.A., Shmeleva V.M., Silina N.N., Tarkovskaya L.R., Papayan L.P. |
| |
|
INFLUENCE OF HYPERHOMOCYSTEINEMIA ON THE ACTIVITY OF CATALASE
|
| Gyrgy A.A., Ribakova L.P., Shmeleva V.M. |
| |
|
INFLUENCE OF INHERITED THROMBOPHILIA WITH RECURRENT PREGNANCY LOSS
|
| Karimi M., Afrasiabi R., Zolghadri Z., Samsami Z., Dehbozorgian J., Yavarian M., Badifard L., Setoodegan F., Jokar N., Imani J., Tavafoghi M., Amiri A., Jamalian N. |
| |
|
INFLUENCE OF INJECTION SITE ON PROPHYLACTIC DOSE ENOXAPARIN BIOAVAILABILITY IN OBESE PATIENTS
|
| Hacquard M., Mainard D., de Maistre E., Wahl D., Lecompte T. |
| |
|
INFLUENCE OF JAK2 V617F AND OTHER GENETIC RISK FACTORS IN THROMBOSIS AND HEMORRHAGE IN PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE DISORDERS [PH(-) MPD]
|
| Moreno M.J., Navarro-Núñez L., Lozano M.L., Bellosillo B., Roldán V., Rivera J., García-Barberá N., Nieto J., Besses C., Vicente V., Martínez C. |
| |
|
INFLUENCE OF LECTIN-LIKE OX-LDL RECEPTOR-1 (LOX-1) AND NITRIC OXIDE SINTHASE (NOS) POLYMORPHISMS IN ATORVASTATIN ANTITHROMBOTIC ACTION AND CARDIOVASCULAR EVENTS RATE
|
| Brandini R., Bruni F., Pasqui A., Pastorelli M., Ciani F., Ghezzi A., Auteri A., Puccetti L. |
| |
|
INFLUENCE OF NANOPOLYMERS WITH DIFFERENT END-FUNCTIONALITIES ON PLATELETS AND COAGULATION. AN EX-VIVO STUDY
|
| Chitlur M., Ware E., Kannan S., Hollon W., Buck S., Rajyalakshmi I., Kannan R., Warrier I., Rajpurkar M., Lusher J. |
| |
|
INFLUENCE OF NEUROHYPOPHYSIAL C-TERMINAL OLYGOPEPTIDES ON PLATELET AGGREGATION
|
| Golubeva M.G., Golubovich V.P. |
| |
|
INFLUENCE OF PAI-1 4G/5G POLYMORPHISM ON PAI-1 ANTIGEN AND MRNA EXPRESSION IN ENDOMETRIOSIS
|
| Ramon L.A., Gilabert-Estelles J., Cosin R., Gilabert J., España F., Castello R., Chirivella M., Estelles A. |
| |
|
INFLUENCE OF PERINATAL RISK FACTORS ON THE DEVELOPMENT OF PLASMATIC COAGULATION IN EXTREMELY PRETERM INFANTS
|
| Hertfelder H., Müller A., Oldenburg J., Birgit Stoffel-Wagner B., Geipel A., Bartmann P., Heep A. |
| |
|
INFLUENCE OF PHOSPHOLIPID SURFACE AND CONCENTRATION IN THROMBOGRAPHY
|
| Membre A., Trossaërt M., Max J.P., Brunette A., Kis A., Lecompte T., Regnault V. |
| |
|
INFLUENCE OF PLATELET GP6 HAPLOTYPES (GP6A AND GP6B)
|
| Trifiro E., Cheli Y., Furihata K., Pulcinelli F.M., Kunicki T.J. |
| |
|
INFLUENCE OF STORAGE CONDITIONS ON THROMBIN GENERATION IN PLATELET POOR PLASMA
|
| Topf H., Rauh M., Lischetzki G. |
| |
|
INFLUENCE OF TESTING FOR INHERITED THROMBOPHILIA ON RECURRENCE OF VENOUS THROMBOEMBOLISM
|
| Coppens M., Reinders J.H., Doggen C.J.M., Middeldorp S., Rosendaal F.R. |
| |
|
INFLUENCE OF THE SOURCE OF PHOSPHOLIPIDS FOR APTT-BASED FIX ASSAYS AND POTENTIAL CONSEQUENCES FOR THE DIAGNOSIS OF MILD/MODERATE HAEMOPHILIA B
|
| Pouplard C., Lequerrec A., Trossaert M., Delahousse B., Guerois C., Giraudeau B., Gruel Y. |
| |
|
INFLUENCE OF THE STREPTOKINASE 36 KDA FRAGMENT ON THE PLASMIN ACTIVITY
|
| Grinenko T.V., Volkov G.L., Yusova E.I. |
| |
|
INFLUENCE OF THROMBOPHILIA ON VASCULAR ACCESS SURVIVAL IN CHRONIC HEMODIALYSIS PATIENTS
|
| Orlovic M., Fritsche I., Landgraf H., Seibt F., Pommer H., Klamroth R. |
| |
|
INHERENT VARIATION INDONOR PLATELET REACTIVITY CONTRIBUTES TO THE QUALITY OF APHERESIS PLATELETS
|
| Garner S.F., Jones C.I., Walton J., Angenent W., Bernard A., Burns P., Stephens J., Ouwehand W.H., Goodall A.H. |
| |
|
INHERITED AND ACQUIRED THROMBOPHILIA IN PATIENTS WITH METABOLIC SYNDROME IN OBSTETRIC-GYNECOLOGIC PRACTICE
|
| Perederyaeva E.B., Pshenichnikova T.B., Makatsaria A.D. |
| |
|
INHERITED BLEEDING DISORDERS- A 14 YEAR RETROSPECTIVE STUDY
|
| Eid S.S., Abu-Ghoush M.W.H., Kamal N.R., Shubeilat T.S. |
| |
|
INHERITED FVII DEFICIENCY MOLECULAR DIAGNOSIS: SCREENING FOR LARGE REARRANGEMENTS IN THE FVII GENE
|
| Giansily-Blaizot M., Thorel D., Khau van Kien P., Behar C., Schved J., Claustres M. |
| |
|
INHERITED PROTHROMBOTIC RISK FACTORS IN CHILDREN WITH CEREBROVASCULAR DISORDERS
|
| Zadro R., Coen Herak D., Radic Antolic M., Basnec Brkic A., Lenicek-Krleza J., Duranovic V., Pavic M., Dodig S. |
| |
|
INHERITED THROMBOPHILIA AND PREECLAMPSIA WITHIN A COHORT OF 5337 WOMEN: RESULTS OF THE MONTREAL PREECLAMPSIA STUDY
|
| Kahn S.R., Platt R., McNamara H., Kramer M. |
| |
|
INHERITED THROMBOPHILIA: INCIDENCE AND IMPACT ON PERINATAL OUTCOME IN SOUTH-WESTERN GREECE
|
| Karakantza M., Androutsopoulos G., Mougiou A., Sakellaropoulos G., Kourounis G., Decavalas G. |
| |
|
INHERITED THROMBOPHILIC ABNORMALITIES AND RISK OF PORTAL VEIN THROMBOSIS: A META-ANALYSIS
|
| Dentali F., Galli M., Gianni M., Ageno W. |
| |
|
INHIBITION BY SOY ISOFLAVONES OF HUMAN POLYMORPHONUCLEAR LEUKOCYTE FUNCTION
|
| Rotondo S., Krauze-Brzósko K., Manarini S., Martelli N., Pecce R., Evangelista V., Donati M., Cerletti C. |
| |
|
INHIBITION OF AIRWAY SMOOTH MUSCLE CELL ADHESION AND MIGRATION BY THE DISINTEGRIN DOMAIN OF ADAM-15
|
| Lu D., Scully M., Xie S., Sukkar M., Chung F., Lu X., Kakkar V. |
| |
|
INHIBITION OF AMINOPHOSPHOLIPID TRANSLOCASE ACTIVITY IN PHOSPHATIDYLSERINE-EXPOSING HUMAN PLATELETS IS INDEPENDENT OF CALPAIN ACTIVITY
|
| Gwozdz A.M., Leung R., Wang H., Bang K.W.A., Packham M.A., Freedman J., Rand M.L. |
| |
|
INHIBITION OF CANCER AND INFLAMMATION-ASSOCIATED THROMBOSIS USING NOVEL INHIBITORS OF NFKB AND OXIDATIVE STRESS PATHWAYS
|
| Mousa S.A., Aljada A., Dier U., Patil G. |
| |
|
INHIBITION OF CYTOSKELETAL ASSEMBLY BY CYTOCHALASIN D PREVENTS ENLARGEMENT OF RAFTS ACCOMPANIED BY GPVI ACCUMULATION IN COLLAGEN-STIMULATED PLATELETS
|
| Suzuki H., Kurihara M., Takayama H. |
| |
|
INHIBITION OF GPIB, BUT NOT GPIIB/IIIA, IMPROVES EXPERIMENTAL STROKE OUTCOME WITHOUT BLEEDING COMPLICATIONS
|
| Pozgajova M., Kleinschnitz C., Pham M., Bendszus M., Stoll G., Nieswandt B. |
| |
|
INHIBITION OF MEASURED THROMBIN GENERATION IN HUMAN PLASMA BY APIXABAN: A PREDICTIVE MATHEMATICAL MODEL BASED ON EXPERIMENTALLY DETERMINED RATE CONSTANTS
|
| Luettgen J.M., Wang Z., Seiffert D.A., Rendina A.R., Knabb R.M., Ogletree M.L. |
| |
|
INHIBITION OF MICROPARTICLE RELEASE TRIGGERS ENDOTHELIAL APOPTOSIS
|
| Abid-Hussein M.N., Böing A.N., Sturk A., Hau C.M., Nieuwland R. |
| |
|
INHIBITION OF P2Y12 BY AZD6140 REDUCES THROMBUS FORMATION AND PROCOAGULANT ACTIVITY ON COLLAGEN AND ATHEROSCLEROTIC PLAQUES
|
| Kuijpers M.J.E., Cosemans J.M.E.M., van der Meijden P.E.J., Feijge M.A.H., Heemskerk J.W.M. |
| |
|
INHIBITION OF PLASMINOGEN/PLASMINOGEN ACTIVATOR SYSTEM BY ANGIOSTATIN-LIKE PLASMINOGEN FRAGMENTS IS INVOLVED IN MECHANISM OF ANTIANGIOGENESIS
|
| Aisina R.B., Mukhametova L.I., Gulin D.A., Larin S.S., Gershkovich K.B., Levashov M.Y., Varfolomeyev S.D. |
| |
|
INHIBITION OF PLATELET AGGREGATION: A NOVEL EFFECT OF C-REACTIVE PROTEIN
|
| Kreutz R.P., Yoho J., Tantry U.S., Bliden K.P., Gurbel P.A. |
| |
|
INHIBITION OF PLATELET FUNCTION BY THE ANTI-VON WILLEBRAND FACTOR APTAMER, ARC1779
|
| Merlino P.G., Gilbert M., Lagasse H., Diener J.L., Marsh H. |
| |
|
INHIBITION OF PLATELET-DERIVED GROWTH FACTOR-BB (PDGF-BB) FUNCTION BY FACTOR VII ACTIVATING PROTEASE (FSAP): ROLE OF PROTEASE NEXIN-1 (PN-1) AND LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP)
|
| Muhl L., Nykjaer A., Monard D., Wygrecka M., Preissner K.T., Kanse S.M. |
| |
|
INHIBITION OF PROTEASE-ACTIVATED RECEPTOR (PAR)-4 PROTECTS FROM MULTI-ORGAN FAILURE IN A MURINE MODEL OF DISSEMINATED INTRAVASCULAR COAGULATION (DIC)
|
| Slofstra S.H., Groot A.P., Reitsma P.H., Lindhout T., ten Cate H., Spek C.A. |
| |
|
INHIBITION OF THROMBIN GENERATION BY IDRAPARINUX AND THE INFLUENCE OF RFVIIA
|
| Gerotziafas G.T., Verdy E., Chakroun T., Samama M.M., Elalamy I. |
| |
|
INHIBITION OF THROMBOSIS BY AZD6140 VIA SELECTIVE BLOCKADE OF THE P2Y12 RECEPTOR IN A MURINE LASER-INJURY MODEL
|
| Patil S.B.G., Norman K.E., Robins S.J., Crosdale D.J., Nylander S., Francis S.E., Storey R.F. |
| |
|
INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR TYROSINE KINASES IMPAIRS ADIPOSE TISSUE DEVELOPMENT IN MOUSE MODELS OF OBESITY
|
| Lijnen R.H., Van Hoef B., Kemp D.M. |
| |
|
INHIBITOR AGAINST F V MONTORING WITH THROMBIN GENERATION ASSAYS
|
| Siegemund T., Siegemund R., Petros S., Engelmann L. |
| |
|
INHIBITOR ANTIBODY LE2E9 AGAINST FACTOR VIII C1 DOMAIN INHIBITS PHOSPHOLIPID BINDING AND ALTERS FACTOR XASE ENZYME COMPLEX FORMATION
|
| Gilbert G.E., Novakovic V., Cullinan D.B., Jacquemin M. |
| |
|
INHIBITOR DEVELOPMENT IN 3 PATIENTS WITH HEMOPHILIA A AFTER INTENSIVE EXPOSURE TO FVIII CONCENTRATES BY CONTINUOUS INFUSION DATA FROM SLOVENIA
|
| Kitanovski L., Andolj[scaron]ek D., Benedik Dolni[ccaron]ar M. |
| |
|
INHIBITOR DEVELOPMENT IN PATIENTS WITH HEMOPHILIA A TREATED WITH SUCROSE-FORMULATED RECOMBINANT FACTOR VIII
|
| Maas-Enriquez M., Gorina E., Bajwa N., Lemm G. |
| |
|
INHIBITOR DEVELOPMENT IN SEVERE HEMOPHILIA A: IS THE RISK ASSOCIATED WITH PRODUCT TYPE?
|
| Jain N., Zinderman C., Baker J., Wise R., Silverman T. |
| |
|
INHIBITOR OF FVII IN CONGENITAL SEVERE FACTOR VII DEFICIENCY
|
| Batorova A., Mariani G., Ingerslev J., Schved J., Auerswald G., Herrmann F. |
| |
|
INHIBITORY ACTIVITY OF TISSUE FACTOR PATHWAY INHIBITOR BETA EXPRESSED BY E COLI AND EXPRESSION IN NORMAL HUMAN TISSUE
|
| Moatti D., Hathcock J.J., Nemerson Y. |
| |
|
INHIBITORY EFFECT OF COFFEE ON PLATELET AGGREGATION
|
| Renda G., Zurro M., Malatesta G., Tatasciore A., Sciartilli A., Gravina M., Zimarino M., De Caterina R. |
| |
|
INITIAL INTRAVENOUS EXPERIENCE WITH PRT060128 (PRT128), AN ORALLY-AVAILABLE, DIRECT-ACTING, AND REVERSIBLE P2Y12 INHIBITOR
|
| Lieu H.D., Conley P.B., Andre P., Leese P.T., Romanko K., Phillips D.R., Jurek M., Meloni A., Hutchaleelaha A., Gretler D.D. |
| |
|
INK4A/ARF DEFICIENT MICE HAVE A DEFICIENT PLATELET FUNCTION
|
| Bellido-Martin L., Serrano M., Perez-Pujol S., Serratosa J., Escolar G., Garcia de Frutos P. |
| |
|
INNOVANCE D-DIMER ASSAY TO ASSESS THE INDIVIDUAL RISK OF VENOUS THROMBOEMBOLISM (VTE) RECURRENCE AFTER ANTICOAGULATION (OAT) WITHDRAWAL
|
| Legnani C., Cosmi B., Cini M., Mattarozzi S., Palareti G. |
| |
|
INR RESULTS OF THE COAGUCHEK XS PLUS SYSTEM ARE EQUIVALENT TO THOSE OF THE COAGUCHEK XS SYSTEM
|
| Plesch W.J., Wolf T., Dikkeschei B. |
| |
|
INR STANDARDIZATION: FRENCH EXPERIENCE OF AN EXTERNAL QUALITY ASSESSMENT PROGRAM
|
| Bon C., Meley R. |
| |
|
INSUFFICIENT INHIBITION OF PLATELET THROMBOXANE SYNTHESIS IS ASSOCIATED WITH GREATER CORONARY ARTERY DISEASE EVALUATED BY ANGIOGRAPHY
|
| Santos M.T., Fuset M.M.P., Ruano M., Moscardo A., Valles J. |
| |
|
INSULIN INHIBITS TISSUE FACTOR EXPRESSION IN MONOCYTES
|
| Gerrits J., Akkerman J. |
| |
|
INSULIN-DEPENDENT CHANGES IN PAI-1 AND T-PA LEVELS AFTER A 6-MO TREATMENT WITH R-HGH IN GROWTH HORMONE DEFICIENT (GHD) ADULTS
|
| Di Minno M., Cirillo F., Palmieri V., Di Somma C., Beck-Peccoz P., Lombardi G. |
| |
|
INTEGRATED DIAGNOSTIC STRATEGY FOR VENOUS THROMBOEMBOLISM
|
| Wells P.S. |
| |
|
INTEGRIN-LINKED KINASE (ILK) IN PLATELET ALPHAIIB-BETA3 SIGNALING AND ARTERIAL THROMBOSIS
|
| Arias-Salgado E.G., Rodriguez R.B., Butta N., Garcia-Munoz S., Parrilla R., Ayuso M.S. |
| |
|
INTENSIVE PLASMA EXCHANGE WAKES UP PATIENT WITH TTP IN COMA
|
| Stankovic S.G., Cevreska L., Karanfilski O. |
| |
|
INTERACTION AND FUNCTIONAL ASSOCIATION OF PROTEIN-DISULFIDE ISOMERASE WITH V3 INTEGRIN ON ENDOTHELIAL CELLS
|
| Szymanski J., Swiatkowska M., Padula G., Cierniewski C.S. |
| |
|
INTERACTION BETWEEN ORAL CONTRACEPTIVE USE AND COAGULATION FACTOR LEVELS IN DEEP VEIN THROMBOSIS
|
| Zotz R.B., Klöckner S., Scharf R.E., Gerhardt A. |
| |
|
INTERACTIONS WITH P-SELECTIN AND ANTIMETASTATIC ACTIVITIES OF NADROPARIN AND UFH
|
| Alban S., Ludwig R.J. |
| |
|
INTERFERENCE OF FACTOR V LEIDEN ON PROTEIN S ACTIVITY. EVALUATION OF A NEW PROTHROMBIN TIME-BASED ASSAY
|
| Chantarangkul V., Tripodi A., Asti D., Biguzzi E., Mannucci P.M. |
| |
|
INTERFERON GAMMA +874A/T AND INTERLEUKIN-4 INTRON3 VNTR GENE POLYMORPHISMS IN CHINESE PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA
|
| Chen X., Xu J., Zhou Z., Chen Z., Zhou Y., Ren Q., Han Z., Yang R. |
| |
|
INTER-LABORATORY VARIATION AND THE EFFECT OF THE TYPE OF FLUORIMETER ON THE RESULTS OF THE TECHNOTHROMBIN THROMBIN GENERATION ASSAY
|
| Meijer P., Kluft C. |
| |
|
INTERLEUKIN-1B GENE HAPLOTYPES AND INFLAMMATORY/PROCOAGULANT RESPONSE OF HUMAN MONONUCLEAR CELLS
|
| Iacoviello L., Latella M., Magnacca S., de Gaetano M., Quaquaruccio G., Graziano M., Di Castelnuovo A., Lorenzet R., Napoleone E., Rogus J., Hutner K., Donati M.B. |
| |
|
INTERLEUKINS GENES TAG-SNP HAPLOTYPES AND RISK OF MYOCARDIAL INFARCTION: A POPULATION BASED CASE-CONTROL STUDY
|
| Iacoviello L., Tayo B., Di Castelnuovo A., Quaquaruccio G., Liang Y., Dorn J., Novak N., Donati M.B., Trevisan M. |
| |
|
INTERMEDIATE-DOSE PROPHYLAXIS EXPERIENCE FOR KOREAN HEMOPHILIA PATIENTS
|
| k. Yoo S., Kim J.Y., Choi K.D. |
| |
|
INTER-OBSERVER RELIABILITY OF MEASURES TO ASSESS THE POST-THROMBOTIC SYNDROME (PTS)
|
| Rodger M.A., Kahn S.R., Kovacs M.J. |
| |
|
INTERRELATION BETWEEN GENETIC POLYMORPHISM OF HEMOSTATIC SYSTEM AND CORONARY HEART DISEASE IN PATIENTS WITH OBESITY UNDERWENT CORONARY ARTERY BYPASS GRAFTING
|
| Supryadkina T., Vorobyova N., Dvoryashina I., Galieva L. |
| |
|
INTRACELLULAR DEGRADATION OF NATURALLY OCCURRING PROTEIN C (PC) MUTANTS
|
| Nishio M., Koyama T., Nakahara M., Egawa N., Hirosawa S. |
| |
|
INTRACELLULAR EVALUATION OF ER TARGETING ELUCIDATES A MILD FORM OF INHERITED COAGULATION DEFICIENCY
|
| Rizzotto L., Pinotti M., Pinton P., Rizzuto R., Bernardi F. |
| |
|
INTRACRANIAL AND SPINAL HEMORRHAGE IN ADULT HEMOPHILIA A IN SIRIRAJ HOSPITAL, THAILAND
|
| Chinthammitr Y., Ruchutrakool T., Suwanawiboon B., Nakkinkun Y., Ayprasert N., Issaragrisil S. |
| |
|
INTRACRANIAL HEMORRHAGE IN AN ACUTE ITP PATIENT WITH MODERATE THROMBOCYTOPENIA
|
| Kim J., Lee J., Lee K. |
| |
|
INTRACRANIAL STENTING IN FOUR PATIENTS WITH ACUTE ISCHEMIC STROKE
|
| Amistà P., Munari M., Sartori M.T., Volpin S.M., Pavesi G., Basile A.M., Cavasin N. |
| |
|
INTRACRANIAL THROMBOSIS COMPLICATING THE MANAGEMENT OF HEMOPHILIC ARTHROPATHY: ANTICOAGULANT TREATMENT IN A CASE WITH HEMOPHILIA B
|
| Akarsu S., Durukan Tosun M., Yildirim H., Kabakus N., Kaplan M. |
| |
|
INTRA-SUBJECT VARIABILITY OF THROMBOELASTOGRAPHIC PARAMETERS FOLLOWING RFVIIA IN VIVO ADMINISTRATION IN HAEMOPHILIA PATIENTS: A MULTI-CENTRE, RANDOMIZED TRIAL
|
| Kenet G., Stenmo C.B., Blemings A., Wegert W., Goudemand J., Krause M., Schramm W., Ingerslev J., Martinovitz U. |
| |
|
INVESTIGATING POSSIBLE MECHANISMS OF THE FACTOR V LEIDEN PARADOX
|
| van Stralen K.J., Doggen C.J.M., Rosendaal F.R. |
| |
|
INVESTIGATION OF ACQUIRED VON WILLEBRAND'S SYNDROME IN PATIENTS WITH HYPOTHYROIDISM
|
| Antonijevic N.M., Mikovic D., Kovac M., Popovic S., Sreckovic V., Beletic A., Jakovljevic B., Perunicic J., Petakov M., Savic S., Vasiljevic Z., Trbojevic B. |
| |
|
INVESTIGATION OF HUMAN RECOMBINANT FVIIA METABOLISM IN A PERFUSED RAT LIVER MODEL
|
| Appa R., Christensen M.S. |
| |
|
INVESTIGATION OF PLATELET BINDING TO COLLAGEN PEPTIDES UNDER FLOW CONDITIONS
|
| Pugh N., Farndale R.W. |
| |
|
INVESTIGATION OF THROMBOPHILIA DURING PREGNANCY AND PUERPERIUM: A STUDY FROM NORTH INDIA
|
| Das R., Ahluwalia J., Garewal G., Malhotra P., Varma S., Prabhakar S., Varma N. |
| |
|
INVESTIGATIONS OF THROMBIN GENERATION TESTS IN WARFARIN-TAKING PATIENTS
|
| Chen H., Ding Q., Wang X., Wang H. |
| |
|
INVOLVEMENT OF THE MAP KINASE JNK1 IN THROMBUS FORMATION
|
| Adam F., Kauskot A., Mazharian A., Ajzenberg N., Berrou E., Bonnefoy A., Hoylaerts M.F., Bryckaert M. |
| |
|
INVOLVEMENT OF THE TPO/MPL PATHWAY IN THE PATHOGENESIS OF INHERITED THROMBOCYTOPENIAS
|
| Heller P.G., Glembotsky A.C., Laguna M.S., Marta R.F., Molinas F.C. |
| |
|
IRIS AN ONGOING, INTERNATIONAL, MULTICENTRE, OPEN, CENTRALLY RANDOMISED, PARALLEL GROUP STUDY WITH TINZAPARIN OR UNFRACTIONATED HEPARIN (UFH) ADMINISTERED SUBCUTANEOUSLY (SC) TO PATIENTS WITH DEEP VEIN THROMBOSIS (DVT) OR PULMUNARY EMBOLISM (PE). THE IRI
|
| Leizorovicz A. |
| |
|
IS BETA3-ARG261 RESPONSIBLE FOR THE EXCLUSIVE BINDING OF ALPHAIIB TO BETA3?
|
| Hauschner H., Rosenberg N., Landau M., Seligsohn U. |
| |
|
IS BIOLOGICAL VARIATION OF PLATELET FUNCTION TESTS TOO HIGH FOR RELIABLE DETECTION OF ASPIRIN RESISTANCE?
|
| Bozic M., Rakusa M., Stegnar M. |
| |
|
IS D-DIMER TESTING COST-EFFECTIVE IN ELDERLY PATIENTS CLINICALLY SUSPECTED OF DEEP VEIN THROMBOSIS?
|
| Dochy E., Penaloza A., Wautrecht J., Melot C., Motte S. |
| |
|
IS HETEROZYGOUS FACTOR XIII DEFICIENCY ASSOCIATED WITH PREGNANCY LOSS? A CASE REPORT
|
| Schroeder V., Kohler H.P. |
| |
|
IS IT POSSIBLE TO TREAT SAFELY AND EFFECTIVELY DEEP VEIN THROMBOSIS WITH CONTINUOUS I.V. INFUSION OF LMWH IN CHILDREN?
|
| Fiamoli V., Blatny J., Zapletal O., Kohlerova S. |
| |
|
IS IT WORTH DIAGNOSING AND TREATING DISTAL DEEP VEIN THROMBOSIS? NO
|
| Righini M. |
| |
|
IS MEAN PLATELET VOLUME A USEFUL MARKER FOR THE 22Q11 DELETION
|
| Davidson S.J., Wong D., Daubeney P.E.F. |
| |
|
IS MODIFICATION OF DIET IN RENAL DISEASE (MDRD) FORMULA SIMILAR TO COCKCROFT-GAULT FORMULA TO ASSESS RENAL FUNCTION IN ELDERLY HOSPITALIZED PATIENTS TREATED WITH LOW MOLECULAR WEIGHT HEPARIN (LMWH)?
|
| Gouin-Thibault I., Pautas E., Mahé I., Descarpentries C., Nivet-Antoine V., Golmard J., Siguret V. |
| |
|
IS PLATELET HYPERREACTIVITY DEFINING STICKY PLATELET SYNDROME A GLOBAL PHENOMENON? THE STUDY OF DETERMINATON OF NORMAL VALUES IN TURKISH HEALTHY SUBJECTS
|
| Tekgunduz E., Demir M., Turgut B., Ufacik O., Altun A. |
| |
|
IS PROTEIN S (PS) DEFICIENCY RARER IN THE BASQUES ?
|
| Bauduer F., Ducout L. |
| |
|
IS THE ASSESSMENT OF CLOPIDOGREL RESPONSIVENESS AFFECTED BY THE ANTICOAGULANT OR MEASUREMENT OF MAXIMUM PLATELET AGGREGATION OR FINAL PLATELET AGGREGATION?
|
| Tantry U.S., Bliden K.P., Etherington A., Gurbel P.A. |
| |
|
IS THE RISK OF VENOUS THROMBOEMBOLISM HIGHER WITH CYPROTERONE CONTRACEPTIVES?
|
| Regina S., Leroux D., Pouplard C., Fimbel B., Delahousse B., Gruel Y. |
| |
|
IS THERE A CONNECTION BETWEEN THORACIC OUTLET SYNDROME AND THROMBOSIS OF SIGMOID SINUS?
|
| Jovanoska V.V., Jovanoski I.I.J. |
| |
|
IS THERE ANY CORRELATION BETWEEN FIBRINOLYTIC ACTIVITY AND BLEEDING SCORE IN TYPE 1 AND POSSIBLE TYPE 1 VON WILLEBRAND DISEASE?
|
| Woods A.I., Sanchez-Luceros A., Blanco A., Grosso S., Kempfer A., Lazzari M. |
| |
|
IS THROMBO-EMBOLIC DISEASE AN HETEROGENEOUS DISEASE ?
|
| Sevestre M.A., Pernod G., Labarere J., Bosson J.L. |
| |
|
IS TODAY'S THROMBOPHILIA PROFILE ADEQUATE IN IDENTIFYING A POSSIBLE CAUSE FOR RECURRENT FETAL LOSS IN WOMEN?
|
| Thiruchelvam A., Sawiah S., Sekaran M., Ayob Y. |
| |
|
ISG12 REGULATES ACTIVITY OF NUCLEAR RECEPTORS THEREBY MODULATING THE VASCULAR RESPONSE TO INJURY
|
| Papac Milicevic N., Ryban L., Zaujec J., Binder C.J., Breuss J.M., Binder E.B., Uhrin P., Binder B.R. |
| |
|
ISOFLAVONE GENISTEIN AND ITS ANALOGUES ENHANCED T-PA PRODUCING ACTIVITY OF HELA S3
|
| Sumi H., Shingu T., Yatagai C., Ohsugi T., Yoshida E., Saito J. |
| |
|
ISOLATED DISTAL DEEP VEIN THROMBOSIS (ID-DVT) IN THE MASTER MULTICENTER ITALIAN REGISTRY
|
| Palareti G., Agnelli G., Ageno W., Moia M., Imberti D., Pistelli R., Rossi R., Verso M. |
| |
|
ISOLATION AND CHARACTERIZATION OF AN ANTI-FACTOR VIII ANTIBODY FROM A PATIENT WITH ACQUIRED HEMOPHILIA
|
| Bukys M.A., Simioni P., Smith K.M., Spiezia L., Kalafatis M. |
| |
|
ISOLATION AND CHARACTERIZATION OF PLASMINOGEN-ACTIVATING PROTEINASE FROM AGKISTRODON HALYS HALYS VENOM
|
| Karbovskyy V.L., Savchuk A.N. |
| |
|
ISOLATION AND CHARACTERIZATION OF PLASMINOGEN-ACTIVATING PROTEINASE FROM AGKISTRODON HALYS HALYS VENOM
|
| Karbovskyy V.L., Savchuk A.N. |
| |
|
ISRAELI PEDIATRIC ONCOLOGY REGISTRY ON CENTRAL VENOUS LINE RELATED COMPLICATIONS
|
| Revel-Vilk S., Yacobovich J., Tamary H., Levy-Shraga Y., Shick S., Stepenski P., Fischer S., Toren A., Yaniv I., Weintraub M., Kenet G. |
| |
|
IVIG-SPARING TREATMENT OF PEDIATRIC ITP: DESIGNING A PROTOCOL IN THE SETTING OF THE LARGE CHILDREN'S HOSPITAL
|
| Lomax C. |
| |
